Background illustration for clinical trials search

Paid Clinical Trials Buffalo

Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs

for
Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure,
Location: Toronto, Cleveland OH, Baltimore MD, New York NY,
Sponsor: European Foundation for Study of Chronic Liver Failure

Sex: All

Age: 18 - 70+

Code: NCT04613921

Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Toronto, Barrie, Detroit MI, Albany NY, Summit NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase 3, Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Toronto, London, Kingston, Pittsburgh PA, York PA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase 3, Recruiting

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Toronto, New York NY, Richmond VA, Chicago IL,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT06137118

Phase 1, Phase 2, Recruiting

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

for
Metastatic Colorectal Cancer
Location: Toronto, Rochester NY, Barrie, Baltimore MD, Trenton NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06792695

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Cancer,
Location: Toronto, Montreal, Commack NY, Sherbrooke,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06219941

Phase 2, Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for
B-cell Malignancies
Location: Toronto, Hackensack NJ, New York NY, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase 1, Phase 2, Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Toronto, Brampton, Cleveland OH, Towson MD, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06467357

Phase 3, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: Toronto, London, Danville PA, Baltimore MD,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Toronto, Pittsburgh PA, Ottawa, Baltimore MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05123482

Phase 1, Phase 2, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Toronto, Brampton, Barrie, Pittsburgh PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Toronto, Barrie, Pittsburgh PA, Lancaster PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Toronto, Cleveland OH, Detroit MI, New York NY,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07081646

Phase 1, Phase 2, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Toronto, Brampton, Barrie, Pittsburgh PA, Detroit MI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

for
B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL),
Location: Toronto, Brampton, Pittsburgh PA, Ottawa,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06526793

Phase 2, Recruiting

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

for
Viral Lung Infection and Acute Respiratory Failure
Location: Toronto, Brampton, Royal Oak MI, Detroit MI, Ottawa,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05624450

Phase 3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Toronto, London, Pittsburgh PA, Ann Arbor MI,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndromes
Location: Toronto, London, Cleveland OH, Canton OH, Columbia MD,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06499285

Phase 3, Recruiting

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma,
Location: Toronto, Cleveland OH, Pittsburgh PA, New York NY,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT04429542

Phase 1, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: Toronto, Maumee OH, Wynnewood PA, Columbia MD,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase 2, Recruiting